AI Drug Discovery & Molecular Design Assistant
AI platform for early drug discovery: molecular generation, target binding affinity prediction, ADMET forecasting, patent landscape analysis, and pre-clinical t
Key Features
- De novo molecular generation with GFlowNets
- Target binding affinity predictor (AlphaFold + GNN)
- ADMET property forecasting
- Patent landscape FTO analysis
- Lead candidate ranking with explainability
Benefits
- Reduce costs with ai drug discovery & molecular design assistant
- Improve operational efficiency
- Scale without complexity
- Enterprise-grade reliability